Article Details

Boehringer's nerandomilast shows promise in phase 3 pulmonary fibrosis study - PMLiVE

Retrieved on: 2025-02-12 12:47:08

Tags for this article:

Click the tags to see associated articles and topics

Boehringer's nerandomilast shows promise in phase 3 pulmonary fibrosis study - PMLiVE. View article details on hiswai:

Excerpt

IPF is one of the more common progressive fibrosing interstitial lung diseases (ILD), affecting approximately three million people worldwide. The ...

Article found on: pmlive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up